Recommended Phase 2 Dose (RP2D) of Nemvaleukin Alfa in Patients (pts) with Advanced Solid Tumors Treated with Less Frequent Intravenous (IV) Dosing (ARTISTRY-3).
Journal of Clinical Oncology(2024)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
Journal of Clinical Oncology(2024)